Open Access. Powered by Scholars. Published by Universities.®

Digital Commons Network

Open Access. Powered by Scholars. Published by Universities.®

Sociology

Thomas Jefferson University

Series

2008

Keyword
Publication

Articles 1 - 6 of 6

Full-Text Articles in Entire DC Network

Women's History Month 2008 Mar 2008

Women's History Month 2008

Diversity Programs

Lectures and Events during Women's History Month, March 2008.


Black History Month 2008 Supplement Feb 2008

Black History Month 2008 Supplement

Diversity Programs

Lectures, Cultural Events and Cuisine during Black Heritage Month, February 2008.


Black Heritage Month 2008 Feb 2008

Black Heritage Month 2008

Diversity Programs

Lectures, Cultural Events and Cuisine during Black Heritage Month, February 2008.


Mlk Day 2008 Jan 2008

Mlk Day 2008

Diversity Programs

Calendar of event in Honor of Dr. Martin Luther King, Jr. Day, January 2008.


Expressions Of Asia 2008 Jan 2008

Expressions Of Asia 2008

Diversity Programs

Lectures, cultural events, and Asian cuisine during Expressions of Asia, January 2008.


Off-Label Psychopharmacologic Prescribing For Children: History Supports Close Clinical Monitoring., Julie M Zito, Albert T Derivan, Christopher J Kratochvil, Daniel J Safer, Joerg M Fegert, Laurence L Greenhill Jan 2008

Off-Label Psychopharmacologic Prescribing For Children: History Supports Close Clinical Monitoring., Julie M Zito, Albert T Derivan, Christopher J Kratochvil, Daniel J Safer, Joerg M Fegert, Laurence L Greenhill

Department of Psychiatry and Human Behavior Faculty Papers

The review presents pediatric adverse drug events from a historical perspective and focuses on selected safety issues associated with off-label use of medications for the psychiatric treatment of youth. Clinical monitoring procedures for major psychotropic drug classes are reviewed. Prior studies suggest that systematic treatment monitoring is warranted so as to both minimize risk of unexpected adverse events and exposures to ineffective treatments. Clinical trials to establish the efficacy and safety of drugs currently being used off-label in the pediatric population are needed. In the meantime, clinicians should consider the existing evidence-base for these drugs and institute close clinical monitoring.